MSH6 mutation in a family affected by Muir-Torre syndrome

Am J Dermatopathol. 2012 Aug;34(6):648-52. doi: 10.1097/DAD.0b013e3182446fe2.

Abstract

Muir-Torre syndrome (MTS), a phenotypic variant of the more common hereditary nonpolyposis colorectal cancer syndrome, or Lynch syndrome, is an autosomal dominantly inherited condition that combines at least one cutaneous sebaceous neoplasm and at least one visceral malignancy. Most patients (~90%) with MTS carry mutations in the MSH2 gene; less than 10% of the cases are associated with a mutation MLH1 gene, and only 3 MTS patients with a pathogenic MSH6 mutation have been previously documented. We report a family affected with MTS in which 3 members (father and 2 sons) were found to harbor a missense mutation c.2633T>C (p.V878A) in exon 4 of the MSH6 gene.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • DNA-Binding Proteins / genetics*
  • Exons / genetics
  • Gene Expression Regulation, Neoplastic
  • Germ-Line Mutation / genetics*
  • Humans
  • Male
  • Middle Aged
  • Muir-Torre Syndrome / diagnosis
  • Muir-Torre Syndrome / genetics*
  • Muir-Torre Syndrome / pathology
  • Sebaceous Gland Neoplasms / diagnosis
  • Sebaceous Gland Neoplasms / genetics*
  • Sebaceous Gland Neoplasms / pathology

Substances

  • DNA-Binding Proteins
  • G-T mismatch-binding protein